Delivery of Nanoparticles for the Treatment of Cardiovascular Diseases
Journal: Global Journal of Obesity, Diabetes and Metabolic Syndrome (Vol.2, No. 1)Publication Date: 2015-12-09
Authors : Ceyda Tuba Sengel;
Page : 018-021
Keywords : ;
Abstract
Cardiovascular diseases are still one of the major causes of death for the people in the world. Biomedical implantable devices are the basic approach on the treatment of cardiovascular diseases. However, unexpected and serious complications can be observed in the case of their usage. Nanotechnology gives a promising perspective to overcome these drawbacks. Nanoparticulate drug delivery systems have develop superior medical solutions and offer better prospects to patients. This review comprehensively summarizes the recent situation, the benefits and the role of nanocarriers in cardiovascular implant technology.
Other Latest Articles
- The Metabolic Syndrome in Hispanics – The Role of Inflammation
- Transient Hypoparathyroidism in Diabetic Ketoacidosis
- Personalized Indirect Calorimeter for Energy Expenditure (EE) Measurement
- Shaping Immune Responses by Dysregulated Adipokines in Obesity
- Anti-Inflammation effects of Radix Astragali Plays an Important Role in Ameliorating Type 2 Diabetes Mellitus
Last modified: 2018-08-29 21:37:49